Search This Blog

Monday, May 4, 2026

MacroGenics expands ZYNYZ royalty deal with Sagard Healthcare, receives $60M upfront

 

MacroGenics expands ZYNYZ royalty deal with Sagard Healthcare, receives $60M upfront for capped future sales royalties

  • Agreement includes potential near-term sales-based milestone payment of up to $20 million to MacroGenics.
  • Sagard receives a capped royalty interest in future global net sales of ZYNYZ under the deal.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)